A staff member checks the packaging quality of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020. (Xinhua/Zhang Yuwei)
It marks China's fifth vaccine eligible for some scale of use, the report said.
BEIJING, March 17 (Xinhua) -- A COVID-19 vaccine developed by the Institute of Microbiology of Chinese Academy of Sciences has obtained the greenlight for emergency use in China, Reuters reported on Monday quoting the institute's statement.
It marks China's fifth vaccine eligible for some scale of use, the report said.
Among the four vaccines China has approved for general public use, three had been approved for small-scale emergency vaccination before gaining clearance for inoculating the wider public, it added.
Jointly developed by the Institute of Microbiology of the Chinese Academy of Sciences and Anhui Zhifei Longcom Biopharmaceutical Co., Ltd., the vaccine was issued with a clinical research permit from the National Medical Products Administration on June 19, 2020. ■
